Elena Gabriela Chiorean, MD, discusses the role of genetic testing in pancreatic cancer.
Gabriela Chiorean, MD
Advertisement
Articles by Gabriela Chiorean, MD
Gabriela Chiorean, MD, associate professor of Medicine at the University of Washington, discusses adverse events of the phase I study of combination therapies for patients with pancreatic cancer.
Advertisement
Latest Updated Articles
Dr. Chiorean on the Role of Genetic Testing in Pancreatic CancerJanuary 7th 2021
Dr. Chiorean on Combination Therapies for Pancreatic CancerJanuary 25th 2017
Advertisement
Advertisement
Trending on OncLive
1
Mocertatug Rezetecan Drives Rapid, Deep Responses in Platinum-Resistant Ovarian and Recurrent/Advanced Endometrial Cancer
2
Trastuzumab Pamirtecan Provides Meaningful Survival Benefit in Pretreated HER2-Expressing Endometrial Cancer
3
Bulumtatug Fuvedotin Yields 32% ORR as First Nectin-4 ADC With Data in Cervical Cancer
4
First-Line Treatment Decisions in Metastatic Pancreatic Cancer: Setting the Stage
5